companies that sell semaglutide Some Pharmacies Are Offering Unauthorized Ozempic Alternatives A South African court has

Clinical Studies A total of 2333 patients with type 1 diabetes and 1852 patients with type 2 diabetes received SYMLIN in controlled clinical trials

This represents one of the fastest CAGR rates ever recorded for a pharmaceutical product and reflects the massive unmet need in obesity treatment globally

Read more: Dr Reddys pauses weight loss drug on quality fears Type 2 diabetes is a growing concern in South Africa which is being driven by rapid urbanisation and changing lifestyles, says the company and further added that the diseases rising prevalence placed a significant pressure on patients and healthcare service

Semaglutide is an FDA-approved injectable drug that is used to treat type 2 diabetes mellitus

Semaglutide was first developed to battle Type-2 diabetes, but then, two years ago, the FDA cleared its use for treatment of chronic obesity, as it effectively curbs the appetites of many who take it